2x2 Cll Algorithms Pdf Free

Algorithms Here you will find big long lists of algorithms for the sections of the CFOP method. I have taken care to choose algorithms that I think are easy to both memorise and perform, and I have arranged them in an order that I think facilitates learning. While I have also endeavoured to ensure they are error free, if you do spot any mistakes you can leave a comment below. F2L If you've read the section of my speedcubing guide, you'll know exactly how I feel about relying on this table instead of intuition. I have presented them anyway so you can see optimal solutions to all the F2L cases.

( R U' R' d R' U2 R) ( U R' U2 R) OLL The OLL algorithms here are numbered using the accepted order found on the (and elsewhere online), so you can always find an alternative to a specific algorithm should you wish. I have chosen these ones because they heavily use three different triggers, which I feel allows for easier memorisation.

Apr 14, 2009 - Registration is fast, simple and absolutely free so please, join our community. To do this, I grouped similar algorithms together, color coded common. 2x2x2 Speedcubing – Contains the Ortega and Guimond Method; 2x2x2. I like the 2x2 because it has Guimond which I wanted to get around to learning. Speedcubing101 Algorithms for CLL, EG-1 and EG-2. R U R' U R U2 R'. U' L' U R2 U' L U2 R' U' R2. R U' L' U R' U' L. U' B' U L2 F2 U F'.

Simply learn the three triggers, and you nearly know most of the algorithms already. V torrente ls models. For the algorithms that don't use these triggers, I have bracketed them to show how I might perform them in sections. Abl80 flex operator's manual. You can sort this list by shape, trigger, and number order, to facilitate easy finding of a specific situation and memorising of the whole list.

Figure 1 First-line Treatment Abbreviations: B = bendamustine; C = cyclophosphamide; Cb = chlorambucil; CLL = chronic lymphocytic leukemia; F = fludarabine; Obi = obinutuzumab; Ofa = ofatumumab; R = rituximab. *More advanced age, risk for toxicity, renal impairment, or patient preference; ˆIn case of contraindication for ibrutinib, with Pneumocystic jiroveci pneumonia prophylaxis and cytomegalovirus monitoring; ˆˆIn case of contraindication for both ibrutinib and idelalisib; ∼Take into account decreased toxicity with R versus increased progression-free survival with obi. Figure 2 Second-line Treatment Abbreviations: B = bendamustine; C = cyclophosphamide; Cb = chlorambucil; CLL = chronic lymphocytic leukemia; F = fludarabine; Obi = obinutuzumab; Ofa = ofatumumab; R = rituximab. *Late relapse: > 24 to 36 months after FCR or BR or > 6 to 12 months after CB anti-CD20 antibody; ˆIn case of contraindication for ibrutinib, with Pneumocystic jiroveci pneumonia prophylaxis and cytomegalovirus monitoring; ∼Only if risk factors for non-relapse mortality (age, World Health Organization Performance Score, comorbidity, No 10/10 human leukocyte antigen-matched donor, female donor for male patients) are low.